دورية أكاديمية
4D Flow Cardiac MR in Primary Mitral Regurgitation.
العنوان: | 4D Flow Cardiac MR in Primary Mitral Regurgitation. |
---|---|
المؤلفون: | Gorecka M; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Cole C; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Bissell MM; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Craven TP; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Chew PG; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Dobson LE; Department of Cardiology, Wythenshawe Hospital, Manchester University NHS Trust, Manchester, UK., Brown LAE; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Paton MF; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Higgins DM; Philips, Farnborough, England, UK., Thirunavukarasu S; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Sharrack N; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Javed W; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Kotha S; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Giannoudi M; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Procter H; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Parent M; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Kidambi A; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Swoboda PP; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Plein S; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Levelt E; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Garg P; Norwich Medical School, University of East Anglia, Norwich, UK., Greenwood JP; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. |
المصدر: | Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2024 Feb 12. Date of Electronic Publication: 2024 Feb 12. |
Publication Model: | Ahead of Print |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9105850 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-2586 (Electronic) Linking ISSN: 10531807 NLM ISO Abbreviation: J Magn Reson Imaging Subsets: MEDLINE |
أسماء مطبوعة: | Publication: <2005-> : Hoboken , N.J. : Wiley-Liss Original Publication: Chicago, IL : Society for Magnetic Resonance Imaging, c1991- |
مستخلص: | Background: Four-dimensional-flow cardiac MR (4DF-MR) offers advantages in primary mitral regurgitation. The relationship between 4DF-MR-derived mitral regurgitant volume (MR-Rvol) and the post-operative left ventricular (LV) reverse remodeling has not yet been established. Purpose: To ascertain if the 4DF-MR-derived MR-Rvol correlates with the LV reverse remodeling in primary mitral regurgitation. Study Type: Prospective, single-center, two arm, interventional vs. nonintervention observational study. Population: Forty-four patients (male N = 30; median age 68 [59-75]) with at least moderate primary mitral regurgitation; either awaiting mitral valve surgery (repair [MVr], replacement [MVR]) or undergoing "watchful waiting" (WW). Field Strength/sequence: 5 T/Balanced steady-state free precession (bSSFP) sequence/Phase contrast imaging/Multishot echo-planar imaging pulse sequence (five shots). Assessment: Patients underwent transthoracic echocardiography (TTE), phase-contrast MR (PMRI), 4DF-MR and 6-minute walk test (6MWT) at baseline, and a follow-up PMRI and 6MWT at 6 months. MR-Rvol was quantified by PMRI, 4DF-MR, and TTE by one observer. The pre-operative MR-Rvol was correlated with the post-operative decrease in the LV end-diastolic volume index (LVEDVi). Statistical Tests: Included Student t-test/Mann-Whitney test/Fisher's exact test, Bland-Altman plots, linear regression analysis and receiver operating characteristic curves. Statistical significance was defined as P < 0.05. Results: While Bland-Altman plots demonstrated similar bias between all the modalities, the limits of agreement were narrower between 4DF-MR and PMRI (bias 15; limits of agreement -36 mL to 65 mL), than between 4DF-MR and TTE (bias -8; limits of agreement -106 mL to 90 mL) and PMRI and TTE (bias -23; limits of agreement -105 mL to 59 mL). Linear regression analysis demonstrated a significant association between the MR-Rvol and the post-operative decrease in the LVEDVi, when the MR-Rvol was quantified by PMRI and 4DF-MR, but not by TTE (P = 0.73). 4DF-MR demonstrated the best diagnostic performance for reduction in the post-operative LVEDVi with the largest area under the curve (4DF-MR 0.83; vs. PMRI 0.78; and TTE 0.51; P = 0.89). Data Conclusion: This study demonstrates the potential clinical utility of 4DF-MR in the assessment of primary mitral regurgitation. Evidence Level: 2 TECHNICAL EFFICACY: Stage 5. (© 2024 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.) |
References: | Dziadzko V, Clavel M-A, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: A community cohort study. Lancet 2018;391(10124):960-969. Bonow RO, O'Gara PT, Adams DH, et al. 2020 Focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2020;75(17):2236-2270. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2017;38(36):2739-2791. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;143(5):e72-e227. Gajjar K, Kashyap K, Badlani J, Williams RB, Biederman RWW. A review of the pivotal role of cardiac MRI in mitral valve regurgitation. Echocardiography 2021;38(1):128-141. Myerson SG. CMR in evaluating valvular heart disease: Diagnosis, severity, and outcomes. Cardiovasc Imaging 2021;14(10):2020-2032. Penicka M, Vecera J, Mirica DC, Kotrc M, Kockova R, Van Camp G. Prognostic implications of magnetic resonance-derived quantification in asymptomatic patients with organic mitral regurgitation: Comparison with doppler echocardiography-derived integrative approach. Circulation 2018;137(13):1349-1360. Uretsky S, Gillam L, Lang R, et al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: A prospective multicenter trial. J Am Coll Cardiol 2015;65(11):1078-1088. Dyverfeldt P, Bissell M, Barker AJ, et al. 4D flow cardiovascular magnetic resonance consensus statement. J Cardiovasc Magn Reson 2015;17:72. Blanken CPS, Farag ES, Boekholdt SM, et al. Advanced cardiac MRI techniques for evaluation of left-sided valvular heart disease. J Magn Reson Imaging 2018;48(2):318-329. Feneis JF, Kyubwa E, Atianzar K, et al. 4D flow MRI quantification of mitral and tricuspid regurgitation: Reproducibility and consistency relative to conventional MRI. J Magn Reson Imaging 2018;48(4):1147-1158. Fidock B, Archer G, Barker N, et al. Standard and emerging CMR methods for mitral regurgitation quantification. Int J Cardiol 2021;331:316-321. Mills MT, Grafton-Clarke C, Williams G, et al. Feasibility and validation of trans-valvular flow derived by four-dimensional flow cardiovascular magnetic resonance imaging in patients with atrial fibrillation. Wellcome Open Res 2021;6:73. Suri RM, Schaff HV, Dearani JA, et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg 2006;82(3):819-826. Lazam S, Vanoverschelde JL, Tribouilloy C, et al. Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: Analysis of a large, prospective, multicenter, international registry. Circulation 2017;135(5):410-422. Senechal M, MacHaalany J, Bertrand OF, et al. Predictors of left ventricular remodeling after surgical repair or replacement for pure severe mitral regurgitation caused by leaflet prolapse. Am J Cardiol 2013;112(4):567-573. Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: A report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017;30(4):303-371. Garg P, Swift AJ, Zhong L, et al. Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging. Nat Rev Cardiol 2020;17(5):298-312. Suinesiaputra A, Bluemke DA, Cowan BR, et al. Quantification of LV function and mass by cardiovascular magnetic resonance: Multi-center variability and consensus contours. J Cardiovasc Magn Reson 2015;17(1):63. Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson 2020;22(1):19. Myerson SG, d'Arcy J, Christiansen JP, et al. Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantification. Circulation 2016;133(23):2287-2296. Garg P, Westenberg JJM, van den Boogaard PJ, et al. Comparison of fast acquisition strategies in whole-heart four-dimensional flow cardiac MR: Two-center, 1.5 Tesla, phantom and in vivo validation study. J Magn Reson Imaging 2018;47(1):272-281. Kamphuis VP, Roest AAW, Ajmone Marsan N, et al. Automated cardiac valve tracking for flow quantification with four-dimensional flow MRI. Radiology 2019;290(1):70-78. Robinson S, Rana B, Oxborough D, et al. A guide for performing adult TTE: The British Society of Echocardiography minimum dataset. Echo Res Pract 2020;7(4):G59-G93. Lambert AS. Proximal isovelocity surface area should be routinely measured in evaluating mitral regurgitation: A core review. Anesth Analg 2007;105(4):940-943. Society AT. ATS statement: The six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-117. Gorecka M, Bissell MM, Higgins DM, Garg P, Plein S, Greenwood JP. Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: A comprehensive review. J Cardiovasc Magn Reson 2022;24(1):49. Fidock B, Barker N, Balasubramanian N, et al. A systematic review of 4D-flow MRI derived mitral regurgitation quantification methods. Front Cardiovasc Med 2019;6:103. Juffermans JF, Minderhoud SC, Wittgren J, et al. Multicenter consistency assessment of valvular flow quantification with automated valve tracking in 4D flow CMR. JACC: Cardiovasc Imaging 2021;14(7):1354-1366. Spampinato RA, Jahnke C, Crelier G, et al. Quantification of regurgitation in mitral valve prolapse with four-dimensional flow cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2021;23(1):87. Marsan NA, Westenberg JJ, Ypenburg C, et al. Quantification of functional mitral regurgitation by real-time 3D echocardiography: Comparison with 3D velocity-encoded cardiac magnetic resonance. JACC Cardiovasc Imaging 2009;2(11):1245-1252. Uretsky S, Animashaun IB, Sakul S, et al. American Society of Echocardiography algorithm for degenerative mitral regurgitation: Comparison with CMR. JACC Cardiovasc Imaging 2022;15(5):747-760. |
فهرسة مساهمة: | Keywords: 4D flow; cardiac magnetic resonance; left ventricular reverse remodeling; mitral valve surgery; primary mitral regurgitation; transthoracic echocardiography |
تواريخ الأحداث: | Date Created: 20240212 Latest Revision: 20240212 |
رمز التحديث: | 20240213 |
DOI: | 10.1002/jmri.29284 |
PMID: | 38344930 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1522-2586 |
---|---|
DOI: | 10.1002/jmri.29284 |